Document Type

Poster

Publication Date

11-7-2026

Comments

Presented at the 2026 American Thyroid Association (ATA) Annual Meeting.

Abstract

Introduction

  • Telomerase reverse transcriptase (TERT) promoter mutations occur in follicular cell-derived thyroid neoplasms, often coexisting with other mutations and associated with aggressive clinicopathologic features.
  • The significance of TERT mutations occurring in isolation (iTERT) is unclear.
  • We examined TERT-positive thyroid specimens (preoperative FNA and postoperative FFPE) to evaluate the clinicopathologic significance of this mutation occurring in isolation vs. in conjunction with other genetic alterations.

Language

English

Share

COinS